Adia Med Inc (ADIA)

Adia Med Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003
Revenue Revenue Growth	1.17	0.7	0.01	-	0.2	0.76
Revenue Growth	-	10879.75%	-	-	-74.03%	83.23%
Gross Profit Gross Profit Growth	0.49	0.18	0	-	0.05	0.33
Operating Income Operating Income Growth	-0.24	-0.36	-0.17	-0	-6.04	-0.58
Net Income Net Income Growth	-0.28	-0.4	-0.18	-0	-8.61	-0.6
Earnings Per Share EPS Growth	-0.00	-0.00	-0.00	-0.00	-0.36	-0.04
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024
Adia Labs Adia Labs Growth	0.59	0.45	-
Adia Med Adia Med Growth	0.58	0.25	-
Unallocated Corporate Unallocated Corporate Growth	-	0	-
Biolete Biolete Growth	-	0	0.01
Total Total Growth	1.17	0.7	0.01

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003
Cash & Investments Cash & Investments Growth	0.13	0.08	0.01	0	0.2	0.1
Total Debt Total Debt Growth	0.99	0.8	0.63	0	0.54	0.01
Net Cash (Debt) Net Cash Growth	-0.87	-0.72	-0.62	-0	-0.34	0.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.01	-0.01	-0.01	-0.00	-0.01	0.01

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003
Operating Cash Flow Operating Cash Flow Growth	-0.18	-0.18	-0.34	-0	-3.92	-0.29
Capital Expenditures CapEx Growth	-0.01	-0.01	-0.02	-	-0.07	-0.03
Free Cash Flow Free Cash Flow Growth	-0.18	-0.19	-0.36	-0	-3.99	-0.31
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003
Gross Margin	41.95%	26.22%	34.39%	-	24.42%	42.88%
Operating Margin	-20.26%	-52.03%	-2739.01%	-	-3059.73%	-75.70%
Pretax Margin	-23.66%	-56.45%	-2838.04%	-	-4361.38%	-78.33%
Profit Margin	-23.66%	-56.45%	-2838.04%	-	-4362.65%	-78.55%
FCF Margin	-15.46%	-27.47%	-5600.42%	-	-2020.45%	-41.37%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003
Period Ending	Aug 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003
PS Ratio	12.08	10.51	99.49	-	192.05	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error